Sandu Pharmaceuticals Ltd — Others, 05-04-2025: Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018

Sandu Pharmaceuticals Limited has provided certificates confirming compliance with SEBI regulations for the quarter ended March 31, 2025. The certificates, issued by MUFG Intime India Pvt. Ltd., confirm the status of securities received for dematerialization and that they have been properly listed on stock exchanges. This underscores the company's adherence to operational standards and enhances transparency in its share management processes.

From an investor perspective, this enhanced compliance awareness could signal a positive outlook, potentially strengthening shareholder confidence in the company’s governance and operational integrity.